Journey Medical (DERM) Free Cash Flow (2020 - 2026)

Journey Medical has reported Free Cash Flow for 7 years, with the latest figure at $2.9 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow rose 202.72% year-over-year to $2.9 million; the trailing twelve-month figure through Mar 2026 stood at -$6.7 million (up 3.46% YoY), and the FY2025 full-year result was -$12.4 million, up 48.44% from the prior year.
• Free Cash Flow for Q1 2026 stood at $2.9 million, up from -$6.3 million in the prior quarter.
• The five-year high for Free Cash Flow was $18.7 million in Q3 2023, with the low at -$19.1 million in Q1 2022.
• Historically, Free Cash Flow has averaged -$3.1 million across 5 years, with a median of -$3.3 million in 2022.
• Annual changes were most pronounced in 2022 — Free Cash Flow tumbled 1504.56% — and 2023, when it soared 357.44%.
• Journey Medical's Free Cash Flow stood at -$3.8 million in 2022, then slumped by 330.66% to -$16.5 million in 2023, then soared by 113.47% to $2.2 million in 2024, then slumped by 382.43% to -$6.3 million in 2025, then surged by 146.29% to $2.9 million in 2026.
• The last three Free Cash Flow figures came in at $2.9 million (Q1 2026), -$6.3 million (Q4 2025), and -$2.4 million (Q3 2025), per Business Quant data.